MSD (Italy)

MSD (Italy)

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fourth on the list of largest biomedical companies by revenue. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for MSD (Italy), Italy, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

48%


Total
Publications

164


Total Open
Publications

78


Total
Citations

2.3K


Open Access
Percentage

48%


Total
Publications

164


Total Open
Publications

78


Total
Citations

2.3K

Wikipedia

Website

download

Breakdown

18% 26% 4% 52%

Publisher Open

18%

Both

26%

Other Platform Open

4%

Closed

52%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

024681012141618Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

52%OA Journal

OA Journal 52%

37

Hybrid 15%

11

No Guarantees 33%

24

Other Platform Open

Domain 66%

33

Institution 62%

31

Other Internet 18%

9

Preprint 10%

5

Public 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
33
DOI
Other Internet
9
University of Padua - Padua Research Archive
Institution
7
Università Politecnica delle Marche - Università Politecnica delle Marche
Institution
3
University of Milano-Bicocca - BOA
Institution
3
University of Genoa - CINECA IRIS Institutial Research Information System
Institution
3
Research Square
Preprint
3
Nova Science Publishers, Inc. - Nova Science Publishers
Institution
3
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
3
University of Modena and Reggio Emilia - IRIS UNIMORE
Institution
2
1 / 3

Data updated 18 August 2025

Share

Share

Share